Anxiety :: Teva announces approval of Alprazolam ER Tablets

Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced that the U.S. Food and Drug Administration has granted approval for the Company’s Abbreviated New Drug Application (ANDA) for Alprazolam Extended Release Tablets, 0.5 mg, 1 mg, 2 mg and 3 mg. Shipment of this product will begin immediately.

FDA :: Avanir Pharmaceuticals summarizes outcome of FDA meeting on Zenvia NDA

AVANIR Pharmaceuticals (NASDAQ:AVNR) announced the Company has met with U.S. Food and Drug Administration (FDA) officials to address concerns expressed in the FDA’s October 30, 2006 approvable letter for Zenvia(TM) as a treatment for involuntary emotional expression disorder (IEED) and to present AVANIR’s proposed strategy to gain approval for Zenvia for this indication.

Diet :: Uno Chicago Grill provides nutritional information for diets

Uno Chicago Grill’s President and Chief Executive Officer Frank Guidara issued the following response to the Center for Science in the Public Interest’s (CSPI) recent nutritional evaluation of Uno Chicago Grill’s Pizza Skins appetizer and the request that nutritional information for every item be listed on the menu.

Dr. Anil Singhal Homeopathic Doctor | Dr. Anil Singhal's Blog | Manan - My Memoir by Dr. Anil Singhal | Boger's Legacy | Organon of Medicine | Health Newstrack